Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2003
05/15/2003US20030092637 Novel compounds
05/15/2003US20030092631 IGF antagonist peptides
05/15/2003US20030092630 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases
05/15/2003US20030092623 Inducing proliferation of endothelial cells; use of Bv8 antagonists to treat testicular cancer and hormone dependent tumors; Bv8 is a small protein originally isolated from the skin secretions of the frog Bombina variegata
05/15/2003US20030092607 A stable antibody liquid comprising a precipitated immunoglobulins and water; precipitating with a biocompatible polymer; storage stability
05/15/2003US20030092604 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
05/15/2003US20030092602 Use of neurokinin receptor antagonists to treat androgen-dependent diseases
05/15/2003US20030092601 Microcompetition and human disease
05/15/2003US20030092180 Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo
05/15/2003US20030092177 Preparing preferential cells from mononucler cells in culture; obtain monocytes, incubate with interferon, recover preferental cells
05/15/2003US20030092163 Probiotic bifidobacterium strains
05/15/2003US20030092133 Interleukins-21 and 22
05/15/2003US20030092130 DNA encoding polypeptides having interferon-gamma inducing activity
05/15/2003US20030092120 Novel human K+ ion channel and therapeutic applications thereof
05/15/2003US20030092084 EBV-infected stomach cancer cell line
05/15/2003US20030092069 Hollow nanoparticle for use in the transfer of biopolymer into cells
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030092046 Monomer for use in huaman therapeutics and diagnostics
05/15/2003US20030092044 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders
05/15/2003US20030092043 Melanoma differentiation associated gene - 5 and promoter and uses thereof
05/15/2003US20030092042 Diagnosing cancer in mammals; obtain tissue sample, extract nucleotide sequences, detect galinin gene, determine copy number for gene, compare to control, amplified copy number indicates cancer
05/15/2003US20030092011 Human cDNAs and proteins and uses thereof
05/15/2003US20030091996 Apoptin-associating protein
05/15/2003US20030091974 Detecting compounds capable of exhausting mast cells; culture mast cells, incubate with modulator, measure mast cell death, classify compound
05/15/2003US20030091651 Oil homogenized with sterols; protective coating for stomach
05/15/2003US20030091639 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
05/15/2003US20030091630 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
05/15/2003US20030091622 Process for producing composite preparation containing nucleic acid
05/15/2003US20030091621 Encapsulated drugs
05/15/2003US20030091620 Transdermal drug delivery systems containing quaternary ammonium salts and methods of using the same
05/15/2003US20030091593 In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
05/15/2003US20030091582 Autoimmune diseases; antitumor agents; antiallergens
05/15/2003US20030091574 Combination treatment of pancreatic cancer
05/15/2003US20030091572 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/15/2003US20030091571 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/15/2003US20030091569 Methods for the treatment of carcinoma
05/15/2003US20030091566 Antitumor agents
05/15/2003US20030091562 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
05/15/2003US20030091561 Anticancer agents
05/15/2003US20030091553 Use of histamine to treat liver disease
05/15/2003US20030091549 Antiinflammatory agents; inflammatory bowel disease; gastrointestinal disorders
05/15/2003US20030091537 Anticancer agents; gene coding immunomoderator cytokine protein
05/15/2003US20030091518 Mixture containing plant extracts and oils
05/15/2003US20030091506 Methods of using 22417, a novel human aminoprotease family member
05/15/2003CA2789407A1 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003CA2669810A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2474196A1 Topical use of cytokines and/or chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases
05/15/2003CA2469818A1 Anticancer compositions
05/15/2003CA2469406A1 Anticancer compositions
05/15/2003CA2468399A1 Combretastatin a-4 derivatives having antineoplastic activity
05/15/2003CA2467853A1 Antibody stimulating il-1ra production
05/15/2003CA2466698A1 Cellular vaccines comprising adjuvants
05/15/2003CA2466530A1 Allogenic vaccine that contains a costimulatory polypeptide-expressing tumor cell
05/15/2003CA2466492A1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003CA2466443A1 Selective treatment of il-13 expressing tumors
05/15/2003CA2466303A1 Selective targeting of apoptotic cells
05/15/2003CA2466232A1 Systems for delivery and release of angiotensin-(1-7)
05/15/2003CA2466198A1 Somatic cell derived embryonic stem cells and their differentiated progenies
05/15/2003CA2466138A1 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003CA2466128A1 Antibodies to cd40
05/15/2003CA2466030A1 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003CA2465981A1 Antigen arrays comprising rankl for treatment of bone disease
05/15/2003CA2465921A1 Novel compositions and methods for cancer
05/15/2003CA2465916A1 Treatment of breast cancer
05/15/2003CA2465894A1 Method for treating or preventing inflammatory diseases
05/15/2003CA2465753A1 Orodispersible tablet having high homogeneity and the preparation method thereof
05/15/2003CA2465744A1 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003CA2465713A1 Derivatives of phenoxy-n-'4-(1,1-dioxoisothiazolidin-2-yl)phenyl!-valeramide and other compounds as inhibitors of coagulation factor xa for the treatment of thromboembolic diseases and tumours
05/15/2003CA2465711A1 Aminopyrimidines and pyridines
05/15/2003CA2465695A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2465680A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003CA2465491A1 Mitotic kinesin inhibitors
05/15/2003CA2465416A1 Amine salts of an integrin receptor antagonist
05/15/2003CA2465361A1 Treatment of human cancer with adenoviral vector expressing tnf-.alpha.
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2465100A1 Quinazoline derivatives as antitumor agents
05/15/2003CA2465068A1 Quinazoline derivatives as antitumor agents
05/15/2003CA2464626A1 Method for the in vitro synthesis of short double stranded rnas
05/15/2003CA2464529A1 Method of treating estrogen responsive breast cancer
05/15/2003CA2464145A1 Polymorphic form of rimonabant, method for preparing it and pharmaceutical compositions containing it
05/15/2003CA2462502A1 Improved use of antitumoral compound in cancer therapy
05/15/2003CA2461373A1 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination
05/15/2003CA2461183A1 Use of tyrosine kinase inhibitors for whitening human skin and treating melanocyte dysfunction associated diseases
05/15/2003CA2459745A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/15/2003CA2429147A1 Radiosensitivity enhancers, radiosensitivity-enhancing nucleic acids and proteins in cancer radiotherapy
05/14/2003EP1310555A2 Oligonucleotide modulation of protein kinase C
05/14/2003EP1310554A1 Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
05/14/2003EP1310509A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
05/14/2003EP1310507A2 Novel peptide nucleic acids
05/14/2003EP1310494A1 PPAR (delta) ACTIVATORS
05/14/2003EP1310493A1 N-adamantylalkyl benzamide derivates as p2x7-receptor antagonists
05/14/2003EP1310491A1 Method for producing 1-substituted-1,2,3-triazole derivative
05/14/2003EP1310257A2 Hormonal contraceptive combination
05/14/2003EP1310256A2 Use of prostaglandin A or its derivatives for the treatment of psoriasis
05/14/2003EP1310254A1 Medicinal compositions containing camptothecin derivative and ph regulating agent
05/14/2003EP1310252A1 Injections
05/14/2003EP1310244A2 Compositions comprising an anticancer agent and a polyether block copolymer
05/14/2003EP1309860A2 Method for screening peptides for use in immunotherapy
05/14/2003EP1309721A2 Modulating multiple lineage kinase proteins
1 ... 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 ... 2211